Ceftriaxone 500 Mg Fksa, Ceftriaxone 1 G Fksa, Ceftriaxone 2 G Fksa 500 mg, 1 g, 2 g Powder for solution for injection
PDF Leaflet Revision Date: 15 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various bacterial infections.
Dosage (summary)
Adults: 1-2 g once daily; up to 4 g for severe cases.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; caution in breastfeeding.
Key Drug Interactions
- Calcium-containing products
- Oral anticoagulants
- Aminoglycosides
Contraindications
- Hypersensitivity to ceftriaxone
- Premature neonates
- Full-term neonates with hyperbilirubinaemia
Common side effects
- Eosinophilia
- Leucopenia
- Diarrhoea
- Rash
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with calcium solutions
- Report any unusual symptoms
Serious warnings
- Serious hypersensitivity reactions
- Risk of precipitation with calcium in neonates
Important Disclaimer
The Ceftriaxone 500 Mg Fksa, Ceftriaxone 1 G Fksa, Ceftriaxone 2 G Fksa 500 mg, 1 g, 2 g Powder for solution for injection professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
